Valuation: PolyPeptide Group AG

Market Cap 1.44B 1.59B 1.33B 1.2B 2.27B 149B 2.35B 16B 6.34B 79.87B 5.95B 5.82B 253B P/E 2026 *
53.7x
P/E 2027 * 28.5x
Enterprise Value 1.54B 1.7B 1.42B 1.29B 2.43B 159B 2.51B 17.12B 6.78B 85.47B 6.36B 6.23B 271B EV / Sales 2026 *
3.07x
EV / Sales 2027 * 2.73x
Free-Float
98.54%
Yield 2026 *
-
Yield 2027 * 0.15%
1 day-0.12%
1 week-0.12%
Current month-4.05%
1 month-8.30%
3 months-8.62%
6 months+7.90%
Current year+54.41%
1 week 40.05
Extreme 40.05
40.65
1 month 40.05
Extreme 40.05
44.25
Current year 23.1
Extreme 23.1
50.1
1 year 21.8
Extreme 21.8
50.1
3 years 13.22
Extreme 13.22
50.1
5 years 13.22
Extreme 13.22
146
10 years 13.22
Extreme 13.22
147.4
Manager TitleAgeSince
Chief Executive Officer 54 12/04/2023
Director of Finance/CFO 54 02/01/2024
Chief Tech/Sci/R&D Officer 54 -
Director TitleAgeSince
Director/Board Member 73 01/01/2006
Chairman 69 01/04/2021
Director/Board Member 62 01/01/2021
Date Insider Type Main position Quantity % Market Cap. Importance
11/13/23 A Buy 2,500 0.0075%
10/12/23 A Buy 159,959 0.4829%
4/6/23 A Buy 45,842 0.1384%
Change 5-day change 1-year change 3-year change Capi.($)
-0.12%-0.12%+69.68%+99.90% 1.59B
-0.82%+1.40%+39.64%+143.17% 1,275B
-1.12%+0.16%+44.21%+88.24% 680B
-0.16%+0.43%+26.76%+113.01% 521B
+1.14%+2.04%+43.06%+72.81% 389B
-2.23%-2.89%+55.47%+41.64% 356B
+1.27%+1.72%+30.01%+63.11% 305B
+0.37%-0.23%+3.71%+38.05% 287B
-0.72%-0.63%+37.29%+71.87% 250B
-0.30%-1.03%+34.04%+124.88% 208B
Average -0.27%+0.44%+38.39%+85.67% 427B
Weighted average by Cap. -0.47%+0.76%+36.93%+98.02%

Financials

2026 *2027 *
Net sales 502M 552M 464M 419M 791M 51.87B 818M 5.58B 2.21B 27.84B 2.07B 2.03B 88.18B 576M 634M 532M 481M 907M 59.53B 939M 6.4B 2.54B 31.95B 2.38B 2.33B 101B
Net income 23.5M 25.87M 21.72M 19.62M 37.02M 2.43B 38.32M 261M 103M 1.3B 97.08M 95.03M 4.13B 45.23M 49.78M 41.79M 37.75M 71.23M 4.67B 73.74M 503M 199M 2.51B 187M 183M 7.95B
Net Debt 101M 111M 93.28M 84.26M 159M 10.43B 165M 1.12B 444M 5.6B 417M 408M 17.74B 131M 144M 121M 109M 206M 13.53B 213M 1.45B 576M 7.26B 541M 529M 23B
Projected Income Statement - Annual - PolyPeptide Group AG
Logo PolyPeptide Group AG
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Employees
1,460
Date Price Change Volume
16/11/26 CHF 40.30 -0.12% 6,737
13/11/26 CHF 40.35 -0.12% 12,493
12/11/26 CHF 40.40 0.00% 3,561
11/11/26 CHF 40.40 0.00% 7,433
10/11/26 CHF 40.40 +0.12% 8,948
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - PolyPeptide Group AG
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
43.62EUR
Average target price
46.32EUR
Spread / Average Target
+6.20%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - PolyPeptide Group AG
  1. Stock Market
  2. Stocks
  3. PPGN Stock